Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6257
|
pubmed:dateCreated |
1990-3-5
|
pubmed:abstractText |
In the search for compounds active against human immunodeficiency virus (HIV), we have found that members of a novel series of tetrahydro-imidazo[4,5,1-jk][1,4]-benzodiazepine-2(1H)-one and -thione (TIBO) derivatives inhibit the replication of HIV-1, the main aetiological agent of AIDS, but not of HIV-2, or of any other DNA or RNA viruses. In five cell systems, HIV-1 is inhibited by TIBO derivatives in nanomolar amounts, which are 10(4)-10(5) times lower than the cytotoxic concentration. The unprecedented specificity of these compounds may be due to an interaction with a reverse transcriptase-associated process. By contrast, AZT (3'-azido-2',3'-dideoxythymidine), which is used for the treatment of AIDS, and DDC (2',3'-dideoxycytidine) and DDI (2',3'-dideoxyinosine), whose clinical application is being assessed, inhibit both HIV-1 and HIV-2 at concentrations that, depending on the cell systems, are 2 to 4 orders of magnitude below their cytotoxic concentration. TIBO-derivatives are new chemicals unrelated to any other antiviral agents. We believe that they are the most specific and potent inhibitors of HIV-1 replication studied so far.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines,
http://linkedlifedata.com/resource/pubmed/chemical/Didanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/R 82150,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Zidovudine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
343
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
470-4
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1689015-Animals,
pubmed-meshheading:1689015-Antiviral Agents,
pubmed-meshheading:1689015-Benzodiazepines,
pubmed-meshheading:1689015-CD4-Positive T-Lymphocytes,
pubmed-meshheading:1689015-Cell Line,
pubmed-meshheading:1689015-Cytopathogenic Effect, Viral,
pubmed-meshheading:1689015-Didanosine,
pubmed-meshheading:1689015-Dogs,
pubmed-meshheading:1689015-HIV-1,
pubmed-meshheading:1689015-HIV-2,
pubmed-meshheading:1689015-Humans,
pubmed-meshheading:1689015-Imidazoles,
pubmed-meshheading:1689015-Lymphocytes,
pubmed-meshheading:1689015-Molecular Conformation,
pubmed-meshheading:1689015-Molecular Structure,
pubmed-meshheading:1689015-Reverse Transcriptase Inhibitors,
pubmed-meshheading:1689015-Virus Replication,
pubmed-meshheading:1689015-Zidovudine
|
pubmed:year |
1990
|
pubmed:articleTitle |
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
|
pubmed:affiliation |
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|